{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:51:04Z","timestamp":1791373864886,"version":"4.3.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-59798-9","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:14:57Z","timestamp":1783419297000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a machine learning model to preoperatively predict very early recurrence in patients with hepatitis B virus-related hepatocellular carcinoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Yuting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxiang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zemin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"10360","key":"59798_CR1","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel, A., Meyer, T., Sapisochin, G., Salem, R. & Saborowski, A. Hepatocellular carcinoma. Lancet\u00a0400 (10360), 1345\u20131362 (2022).","journal-title":"Lancet"},{"issue":"3","key":"59798_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74 (3), 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"59798_CR3","doi-asserted-by":"crossref","unstructured":"Reig, M. et al. Bclc strategy for prognosis prediction and treatment recommendations: the 2025 update. J Hepatol 84 (3), 631\u2013654 (2025).","DOI":"10.1016\/j.jhep.2026.03.002"},{"issue":"15","key":"59798_CR4","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva, A. Hepatocellular carcinoma. N Engl. J. Med. 380 (15), 1450\u20131462 (2019).","journal-title":"N Engl. J. Med."},{"key":"59798_CR5","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.2147\/JHC.S544589","volume":"12","author":"Q Wang","year":"2025","unstructured":"Wang, Q. et al. Tumor compression of the hepatic or portal vein predicts the presence of microvascular invasion and satellite nodules in hepatocellular carcinoma: a retrospective study. J. Hepatocell Carcinoma. 12, 2055\u20132067 (2025).","journal-title":"J. Hepatocell Carcinoma"},{"key":"59798_CR6","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.2147\/JHC.S556306","volume":"12","author":"W Luo","year":"2025","unstructured":"Luo, W. et al. Impact of middle hepatic vein resection during hemihepatectomy on surgical outcomes and long-term prognosis in hepatocellular carcinoma: a retrospective study. J. Hepatocell Carcinoma. 12, 2681\u20132692 (2025).","journal-title":"J. Hepatocell Carcinoma"},{"issue":"7","key":"59798_CR7","doi-asserted-by":"publisher","first-page":"111887","DOI":"10.1016\/j.ejso.2026.111887","volume":"52","author":"H Yang","year":"2026","unstructured":"Yang, H. et al. Wide resection margin fails to demonstrate improved survival outcomes in early-stage hepatocellular carcinoma following anatomical resection: a propensity score-matched analysis from two tertiary centers. Eur. J. Surg. oncology: J. Eur. Soc. Surg. Oncol. Br. Association Surg. Oncol. 52 (7), 111887 (2026).","journal-title":"Eur. J. Surg. oncology: J. Eur. Soc. Surg. Oncol. Br. Association Surg. Oncol."},{"issue":"2","key":"59798_CR8","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1245\/s10434-022-12494-0","volume":"30","author":"Y Endo","year":"2023","unstructured":"Endo, Y. et al. A novel online calculator to predict risk of microvascular invasion in the preoperative setting for hepatocellular carcinoma patients undergoing curative-intent surgery. Ann. Surg. Oncol. 30 (2), 725\u2013733 (2023).","journal-title":"Ann. Surg. Oncol."},{"issue":"1D","key":"59798_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6004\/jnccn.2023.7069","volume":"22","author":"Y He","year":"2024","unstructured":"He, Y. et al. Development and validation of a nomogram for predicting postoperative early relapse and survival in hepatocellular carcinoma. J. Natl. Compr. Cancer Netw. 22 (1D), 1\u20137 (2024).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"59798_CR10","doi-asserted-by":"crossref","unstructured":"Liu, L. et al. Development and comprehensive validation of a predictive prognosis model for very early hcc recurrence within one year after curative resection: a multicenter cohort study. Int J. Surg. 110 (6), 3401\u20133411 (2024).","DOI":"10.1097\/JS9.0000000000001467"},{"issue":"2","key":"59798_CR11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.21037\/hbsn-22-469","volume":"12","author":"D Xie","year":"2023","unstructured":"Xie, D. et al. A review of 2022 chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights. Hepatobil Surg. Nutr. 12 (2), 216\u2013228 (2023).","journal-title":"Hepatobil Surg. Nutr."},{"issue":"2","key":"59798_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","volume":"82","author":"AFT European","year":"2025","unstructured":"European, A. F. T. Easl clinical practice guidelines on the management of hepatocellular carcinoma. J. Hepatol. 82 (2), 315\u2013374 (2025).","journal-title":"J. Hepatol."},{"issue":"2","key":"59798_CR13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.21037\/hbsn-20-466","volume":"11","author":"J Zeng","year":"2022","unstructured":"Zeng, J. et al. Development of a machine learning model to predict early recurrence for hepatocellular carcinoma after curative resection. Hepatobil Surg. Nutr. 11 (2), 176\u2013187 (2022).","journal-title":"Hepatobil Surg. Nutr."},{"issue":"43","key":"59798_CR14","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.3748\/wjg.v29.i43.5804","volume":"29","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Development of a machine learning-based model for predicting risk of early postoperative recurrence of hepatocellular carcinoma. World J. Gastroenterol. 29 (43), 5804\u20135817 (2023).","journal-title":"World J. Gastroenterol."},{"issue":"13","key":"59798_CR15","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1056\/NEJMra2302038","volume":"388","author":"CJ Haug","year":"2023","unstructured":"Haug, C. J. & Drazen, J. M. Artificial intelligence and machine learning in clinical medicine, 2023. N Engl. J. Med. 388 (13), 1201\u20131208 (2023).","journal-title":"N Engl. J. Med."},{"key":"59798_CR16","doi-asserted-by":"crossref","unstructured":"Vithayathil, M. et al. Machine learning based radiomic models outperform clinical biomarkers in predicting outcomes after immunotherapy for hepatocellular carcinoma. J Hepatol 83 (4), 959\u2013970  (2025).","DOI":"10.1016\/j.jhep.2025.04.017"},{"issue":"4","key":"59798_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1159\/000542572","volume":"14","author":"M Kudo","year":"2025","unstructured":"Kudo, M. et al. First-line lenvatinib plus pembrolizumab for hepatocellular carcinoma: post hoc analysis of japanese patients from the phase 3 leap-002 trial. Liver Cancer. 14 (4), 365\u2013377 (2025).","journal-title":"Liver Cancer"},{"issue":"8","key":"59798_CR18","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3748\/wjg.v29.i8.1243","volume":"29","author":"R Nevola","year":"2023","unstructured":"Nevola, R. et al. Predictors of early and late hepatocellular carcinoma recurrence. World J. Gastroenterol. 29 (8), 1243\u20131260 (2023).","journal-title":"World J. Gastroenterol."},{"key":"59798_CR19","doi-asserted-by":"crossref","unstructured":"Zhang, J. et al. Nomogram for predicting early recurrence of hepatocellular carcinoma with narrow resection margin. Sci Rep 14 (1), 28103 (2024).","DOI":"10.1038\/s41598-024-79760-x"},{"key":"59798_CR20","doi-asserted-by":"publisher","first-page":"1714314","DOI":"10.3389\/fimmu.2026.1714314","volume":"17","author":"J Li","year":"2026","unstructured":"Li, J. et al. Prognostic value of lymphatic vessel density in the capsule of early-stage hepatocellular carcinoma: implications for postoperative recurrence risk. Front. Immunol. 17, 1714314 (2026).","journal-title":"Front. Immunol."},{"issue":"6","key":"59798_CR21","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.jhep.2018.08.027","volume":"69","author":"AWH Chan","year":"2018","unstructured":"Chan, A. W. H. et al. Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection. J. Hepatol. 69 (6), 1284\u20131293 (2018).","journal-title":"J. Hepatol."},{"key":"59798_CR22","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.2147\/JHC.S552316","volume":"12","author":"F Meng","year":"2025","unstructured":"Meng, F. et al. Risk factors for recurrence in patients with hepatocellular carcinoma after curative resection or ablation. J. Hepatocell Carcinoma. 12, 2501\u20132511 (2025).","journal-title":"J. Hepatocell Carcinoma"},{"key":"59798_CR23","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.2147\/JHC.S413996","volume":"10","author":"Y Peng","year":"2023","unstructured":"Peng, Y. et al. An overview of traditional chinese medicine in the treatment after radical resection of hepatocellular carcinoma. J. Hepatocell Carcinoma. 10, 2305\u20132321 (2023).","journal-title":"J. Hepatocell Carcinoma"},{"issue":"1","key":"59798_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.21037\/hbsn-22-579","volume":"13","author":"A Herrero","year":"2024","unstructured":"Herrero, A. et al. Management of hepatocellular carcinoma recurrence after liver surgery and thermal ablations: state of the art and future perspectives. Hepatobil Surg. Nutr. 13 (1), 71\u201388 (2024).","journal-title":"Hepatobil Surg. Nutr."},{"key":"59798_CR25","doi-asserted-by":"crossref","unstructured":"Sun, T. et al. The ez-albi and palbi scores contribute to the clinical application of albi in predicting postoperative recurrence of hcc. Sci Rep 15 (1), 9132 (2025).","DOI":"10.1038\/s41598-025-93716-9"},{"issue":"4","key":"59798_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4174\/astr.2023.104.4.195","volume":"104","author":"SO Yun","year":"2023","unstructured":"Yun, S. O., Kim, J. M., Rhu, J., Choi, G. & Joh, J. Fibrosis-4 index, a predictor for prognosis of hepatocellular carcinoma patients after curative hepatectomy even in hepatitis b virus dominant populations. Ann. Surg. Treat. Res. 104 (4), 195 (2023).","journal-title":"Ann. Surg. Treat. Res."},{"key":"59798_CR27","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.2147\/JHC.S562887","volume":"12","author":"D Bayram","year":"2025","unstructured":"Bayram, D. et al. The combined albi-fib-4 score for prognostic stratification in hepatocellular carcinoma: a single center retrospective study. J. Hepatocell Carcinoma. 12, 2811\u20132823 (2025).","journal-title":"J. Hepatocell Carcinoma"},{"issue":"1","key":"59798_CR28","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s12885-024-12187-9","volume":"24","author":"X Hao","year":"2024","unstructured":"Hao, X., Xu, L., Lan, X., Li, B. & Cai, H. Impact of hepatic inflammation and fibrosis on the recurrence and long-term survival of hepatitis b virus-related hepatocellular carcinoma patients after hepatectomy. BMC Cancer. 24 (1), 475 (2024).","journal-title":"BMC Cancer"},{"key":"59798_CR29","doi-asserted-by":"publisher","first-page":"1133308","DOI":"10.3389\/fimmu.2023.1133308","volume":"14","author":"C Chen","year":"2023","unstructured":"Chen, C., Wang, Z., Ding, Y. & Qin, Y. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma. Front. Immunol. 14, 1133308 (2023).","journal-title":"Front. Immunol."},{"issue":"1","key":"59798_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12874-025-02694-z","volume":"25","author":"Y Huang","year":"2025","unstructured":"Huang, Y. et al. Comparison of machine learning methods versus traditional cox regression for survival prediction in cancer using real-world data: a systematic literature review and meta-analysis. BMC Med. Res. Methodol. 25 (1), 243 (2025).","journal-title":"BMC Med. Res. Methodol."},{"issue":"7","key":"59798_CR31","doi-asserted-by":"publisher","first-page":"112902","DOI":"10.1016\/j.isci.2025.112902","volume":"28","author":"J Zhou","year":"2025","unstructured":"Zhou, J., Sui, Y. & Chen, Z. Metastatic hepatic carcinoma: mechanisms, emerging therapeutics, and future perspectives. iScience 28 (7), 112902 (2025).","journal-title":"iScience"},{"key":"59798_CR32","doi-asserted-by":"crossref","unstructured":"Xu, W. et al. Liver metastasis in cancer: molecular mechanisms and management. MedComm 6(3), e70119 (2025).","DOI":"10.1002\/mco2.70119"},{"issue":"11","key":"59798_CR33","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1002\/wjs.70114","volume":"49","author":"GL Laing","year":"2025","unstructured":"Laing, G. L. et al. Random forest machine learning matches human expert accuracy in trauma severity scoring. World J. Surg. 49 (11), 3242\u20133247 (2025).","journal-title":"World J. Surg."},{"issue":"8","key":"59798_CR34","doi-asserted-by":"publisher","first-page":"e70022","DOI":"10.1002\/gepi.70022","volume":"49","author":"V Venkat","year":"2025","unstructured":"Venkat, V. et al. Exploring random forest in genetic risk score construction. Genet. Epidemiol. 49 (8), e70022 (2025).","journal-title":"Genet. Epidemiol."},{"issue":"1","key":"59798_CR35","doi-asserted-by":"publisher","first-page":"35381","DOI":"10.1038\/s41598-025-19289-9","volume":"15","author":"HF Jelinek","year":"2025","unstructured":"Jelinek, H. F., Muteir, I. & Al-Aubaidy, H. Hierarchical random forest model, inflammation and oxidative stress as predictors of the atherogenic index of plasma and diabetes progression. Sci. Rep. 15 (1), 35381 (2025).","journal-title":"Sci. Rep."},{"issue":"3","key":"59798_CR36","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1148\/radiol.2018181494","volume":"289","author":"V Chernyak","year":"2018","unstructured":"Chernyak, V. et al. Liver imaging reporting and data system (li-rads) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology 289 (3), 816\u2013830 (2018).","journal-title":"Radiology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59798-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59798-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59798-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:03:16Z","timestamp":1791370996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59798-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59798"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59798-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was reviewed and approved by the ethics committees of Guangxi Medical University Cancer Hospital (approval number: KY2026390) and The First People\u2019s Hospital of Changde City(approval number: 2025-260-01). Due to the retrospective nature of this study, the requirement for individual informed consent was waived by the ethics committee. All data analyses were performed in strict accordance with the principles of the Declaration of Helsinki, as well as the ethical guidelines established by Guangxi Medical University Cancer Hospital and The First People\u2019s Hospital of Changde City.","order":2,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31191"}}